Lung Cancer Clinical Trials

149 studies are recruiting for lung cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 2

  1. Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

    The purpose of this study is to assess the best time to deliver a message to increase physical activity and how often participants will experience a pain episode in the 24 hours following their receipt of a message to increase physical activity.

    Stage
    Not phased
    Ages
    65 and older
    Site
    Froedtert Hospital, Milwaukee, Wisconsin
    Run by
    Medical College of Wisconsin
  2. Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer

    This clinical trial evaluates whether home-based respiratory muscle training is useful for minimizing side effects in patients undergoing treatment for cancer. Over-activation of the nervous system during breast cancer treatment can result in heart- and lung-related side effects which have the pote…

    Stage
    Not phased
    Ages
    21 and older
    Site
    Roswell Park Cancer Institute, Buffalo, New York
    Run by
    Roswell Park Cancer Institute
  3. Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

    This is a Phase 3, multi-center, randomized and intrasubject controlled study to evaluate the safety and efficacy of abenacianine for injection, a tumor-targeted, activatable fluorescent imaging agent, to identify cancer using NIR imaging in participants undergoing surgery for cancer in the lung. A…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    City of Hope National Medical Center, Duarte, California
    Locations
    9 in total
    Run by
    Vergent Bioscience, Inc.
  4. InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

    This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or has been diagnosed with an early phase of a cancer or a family member who has a family member with a precursor condition for cancer. * The …

    Stage
    Not phased
    Ages
    Any age
    Site
    Dana Farber Cancer Institute, Boston, Massachusetts
    Run by
    Dana-Farber Cancer Institute
  5. Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    This study is being done to find out if a new medicine called PF-08634404, when given with chemotherapy, works better than the present standard treatment (pembrolizumab with chemotherapy) for adults with a type of lung cancer called non-small cell lung cancer (NSCLC) that is either locally advanced…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Pioneer Research Center, Bullhead City, Arizona
    Locations
    440 in total
    Run by
    Pfizer
  6. A Study of Lung Cancer Risk

    The researchers are doing this study to learn more about factors that may increase the risk of lung cancer in people who have never smoked. This information may help predict which people who have never smoked may be more likely to get lung cancer.

    Stage
    Not phased
    Ages
    40 to 74
    Site
    Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  7. Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening

    The investigators proposal is ripe for executing as the investigators seek to leverage this "natural experiment" initiated by the BJC health system to evaluate the effectiveness of the Pink \& Pearl Campaign as an implementation strategy to promote lung cancer screening (LCS) uptake among LCS-eligi…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Barnes-Jewish Hospital West County, Creve Coeur, Missouri
    Run by
    Washington University School of Medicine
  8. Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital

    Inspired by the ongoing Pink \& Pearl Campaign, the breast radiology service of Christian Hospital in north St. Louis County will partner with Siteman Cancer Center to pilot this campaign in its mammography clinics in order to promote awareness, referral, and completion of lung cancer screening (LC…

    Stage
    Not phased
    Ages
    20 and older
    Site
    Barnes-Jewish Christian Hospital, St Louis, Missouri
    Run by
    Washington University School of Medicine
  9. Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENHANCE Trial

    The purpose of this study is to examine the feasibility and effects of 12-week exercise training at different intensities among individuals with advanced lung cancer receiving immune checkpoint inhibitors. The names of the study interventions involved in this study are: * High-intensity interval tr…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Dana-Farber Cancer Institute, Boston, Massachusetts
    Run by
    Dana-Farber Cancer Institute
  10. Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer

    The purpose of this study is to examine the combination of osimertinib and carotuximab to assess the safety and find the recommended dose for treatment of advanced EGFR-mutated non-small cell lung cancer (NSCLC). Safety and tolerability will be measured by the number of dose-limiting toxicities, ac…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Cedars-Sinai Cancer at Beverly Hills (THO), Beverly Hills, California
    Locations
    5 in total
    Run by
    Karen Reckamp, MD, MS
  11. Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies

    This research is being done to collect and store biological specimens (biospecimens) from people with cancer, regardless of tumor type, who are receiving treatments known or thought to have an effect on the immune system. The goal of this discovery and exploratory study is to: * Understand changes …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Johns Hopkins University, Baltimore, Maryland
    Run by
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  12. IDOV-Immune for Advanced Solid Tumors

    This is a Phase I clinical trial evaluating an investigational treatment called IDOV-Immune, a type of oncolytic virus therapy, for adults with advanced solid tumors that have not responded to standard treatments. Oncolytic viruses are designed to infect and destroy cancer cells and have the potent…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Washington University School of Medicine, St Louis, Missouri
    Locations
    5 in total
    Run by
    ViroMissile, Inc.
  13. Distance-Based Exercise to Preserve Function and Prevent Disability

    This clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to exercise in their own home. Treatments for cancer can cause side effects such as fatigue and loss of strength. These side e…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Kaiser Permanente Dublin, Dublin, California
    Locations
    18 in total
    Run by
    Alliance for Clinical Trials in Oncology
  14. Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study

    The purpose of this study is to test the feasibility of the Precise Exercise Regimen for Cancer Care (PERCC) exercise program in participants with stage II-III primary lung cancer.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Dana-Farber Cancer Institute, Boston, Massachusetts
    Run by
    Dana-Farber Cancer Institute
  15. Support for Cancer Patients Awaiting News

    This is a behavioral trial study to pilot test a stress management intervention for people with cancer who are undergoing routine cancer scans. The study will involve two pilot testing phases. Initial feasibility will be determined in an Open Trial phase, to inform any needed revisions to the inter…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Amanda Khoudary, Hackensack, New Jersey
    Run by
    Hackensack Meridian Health
  16. A Study of a Side Effects and Resource Navigation Program for People With Cancer

    The purpose of this study is to find out if the navigation program helps participants manage immunotherapy treatment better than usual care. Investigators will also look at how the navigation program impacts participants' quality of life. Investigators will measure quality of life by having partici…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey
    Locations
    8 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  17. Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy

    The overall purpose of this study is to evaluate cardiopulmonary toxicity in patients with lung cancer (NSCLC or SCLC) undergoing combined thoracic radiotherapy ± chemotherapy and immunotherapy through timed monitoring and blood sample collection and to identify correlative biomarkers for predictin…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Missouri - Ellis Fischel Cancer Center, Columbia, Missouri
    Locations
    3 in total
    Run by
    Bo Lu
  18. REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)

    To learn about the effects of the investigational drug NKTR-255 in combination with the standard drug durvalumab on locally advanced NSCLC when given after CRT.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    M D Anderson Cancer Center, Houston, Texas
    Run by
    M.D. Anderson Cancer Center
  19. Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer

    The purpose of this research study is to test a new process for diagnosing lung cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this study will have blood sample…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Maryland Baltimore Washington Medical Center, Glen Burnie, Maryland
    Run by
    University of Maryland, Baltimore
  20. Empathic Communication Skills (ECS) Training

    Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma …

    Stage
    Not phased
    Ages
    18 to 100
    Site
    BAPTIST ALLIANCE - MCI (Data Collection Only), Miami, Florida
    Locations
    12 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  21. The Florida ASCENT Study

    The goal of this clinical trial is to adapt, implement, and evaluate MyCarePulse and ASCENT patient navigator to overcome barriers to care among patients with cancer. The main hypotheses it aims to test are: * At the patient level, the intervention will result in higher levels of food security, sel…

    Stage
    Not phased
    Ages
    18 to 100
    Site
    University of Florida, Gainesville, Florida
    Run by
    University of Florida
  22. Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics

    The long-term goal of this program of research is to increase the reach of Lung Cancer Screening (LCS) among low-resource healthcare settings and populations. The proposed project, LUNG-IS, is a mixed-methods, pre-post quasi-experimental design conducted in three Utah safety-net healthcare system c…

    Stage
    Not phased
    Ages
    50 to 80
    Site
    Huntsman Cancer Institute/ University of Utah, Salt Lake City, Utah
    Run by
    University of Utah
  23. Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

    This study's goal is to find out if the kind of side effects people experience from radiation is different depending on the schedule of their radiation treatment. Patients will be randomly assigned to either the 3 Fraction or 5 Fraction schedule of radiation. After patients complete radiation treat…

    Stage
    Not phased
    Ages
    18 and older
    Site
    James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York
    Run by
    University of Rochester
  24. Safety and Efficacy of OBX-115 in Advanced Solid Tumors

    This is a study to investigate the safety and efficacy of an investigational OBX-115 regimen in adult participants with advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    The Angeles Clinic and Research Institute (Melanoma), Los Angeles, California
    Locations
    10 in total
    Run by
    Obsidian Therapeutics, Inc.
  25. EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

    This research study is studying a new blood test to screen for Epidermal Growth Factor Receptor (EGFR) positive lung cancer in healthy individuals at risk for the disease and who cannot undergo regular lung cancer screening. The name of the test used in this research study is: -Circulating free DNA…

    Stage
    Not phased
    Ages
    40 to 80
    Site
    Dana-Farber Cancer Institute, Boston, Massachusetts
    Locations
    6 in total
    Run by
    Dana-Farber Cancer Institute

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.